Brean Murray Starts Human Genome (HGSI) at Buy; Oversold Launch Creates Opportunity
Tweet Send to a Friend
Brean Murray Carret & Co. initiates coverage on Human Genome Sciences (NASDAQ: HGSI) with a Buy. PT $22.00.
Brean analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Brean analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
